NYSE: AUNAAuna Sa Stock
$6.91-0.25 (-3.49%)
Updated Apr 30, 2025
AUNA Price
$6.91
Fair Value Price
N/A
Market Cap
$511.13M
52 Week Low
$6.44
52 Week High
$9.89
P/E
15.6x
P/B
1.28x
P/S
0.43x
PEG
0.25x
Dividend Yield
N/A
Revenue
$1.19B
Earnings
$29.56M
Gross Margin
39.3%
Operating Margin
17.37%
Profit Margin
2.5%
Debt to Equity
3.7
Operating Cash Flow
$226M
Beta
0.49
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AUNA's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
AUNA
Ranked#14 of 42
Ranked#14 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.88 | A | |
| $12.73 | A | |
| $14.21 | A |
Be the first to know about important AUNA news, forecast changes, insider trades & much more!
AUNA News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AUNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AUNA ($6.91) is trading below its intrinsic value of $12.44, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AUNA is good value based on its earnings relative to its share price (15.6x), compared to the US market average (29.18x)
P/E vs Market Valuation
AUNA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more AUNA due diligence checks available for Premium users.
Valuation
AUNA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.6x
Industry
14.9x
Market
29.18x
AUNA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AUNA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AUNA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.28x
Industry
4.38x
AUNA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AUNA price to earnings growth (PEG)
For valuing profitable companies with growth potential
AUNA is good value based... subscribe to Premium to read more.
PEG Value Valuation
AUNA's financial health
Profit margin
Revenue
$285.0M
Net Income
$5.9M
Profit Margin
2.1%
AUNA's Earnings (EBIT) of $205.94M... subscribe to Premium to read more.
Interest Coverage Financials
AUNA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.9B
Liabilities
$1.5B
Debt to equity
3.7
AUNA's short-term liabilities ($525.75M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AUNA's long-term liabilities ($949.33M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AUNA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AUNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$61.6M
Investing
-$17.2M
Financing
-$24.2M
AUNA's operating cash flow ($227.51M)... subscribe to Premium to read more.
Debt Coverage Financials
AUNA vs Medical Care Facility Stocks
Auna Sa Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.